DOI: 10.1055/s-00000017

Experimental and Clinical Endocrinology & Diabetes

Issue 01 · Volume 129 · January 2021 · Sample Issue DOI: 10.1055/s-010-50118

Acknowledgment to the Reviewers

5
A Big Thank You to Our Reviewers in the Past Year!

Article

7
Krysiak, Robert; Szkróbka, Witold; Okopień, Bogusław: Cardiometabolic Risk Factors in Men with Elevated Macroprolactin Content: A Pilot Study
14
Korkmaz, Ozge Polat; Sahin, Serdar; Ozkaya, Hande Mefkure; Apaydin, Tugce; Durmaz, Emine Sebnem; Haliloglu, Ozlem; Durcan, Emre; Kadioglu, Pinar: Primary hypophysitis: Experience of a Single Tertiary Center
22
Krysiak, Robert; Szkróbka, Witold; Okopień, Bogusław: The Impact of Ethinyl Estradiol on Metformin Action on Prolactin Levels in Women with Hyperprolactinemia
29
Slezák, David; Mayer, Otto; Bruthans, Jan; Seidlerová, Jitka; Rychecká, Martina; Gelžinský, Julius; Mateřánková, Markéta; Karnosová, Petra; Wohlfahrt, Peter; Cífková, Renata; Filipovský, Jan: The Prognostic Importance of Impaired Fasting Glycemia in Chronic Coronary Heart Disease Patients
36
Tarboush, Nafez Abu; Abu-Yaghi, Nakhleh E; Al Ejeilat, Laith H; Wahed, Rawand K. Abdel; Jeris, Issa N: Association of Irisin Circulating Level with Diabetic Retinopathy: A Case-Control Study
43
Verdoia, Monica; Pergolini, Patrizia; Rolla, Roberta; Ceccon, Claudia; Caputo, Marina; Aimaretti, Gianluca; Suryapranata, Harry; De Luca, Giuseppe: Use of Metformin and Platelet Reactivity in Diabetic Patients Treated with Dual Antiplatelet Therapy
50
Tanaka, Ken-ichiro; Kanazawa, Ippei; Notsu, Masakazu; Sugimoto, Toshitsugu: Higher Serum Uric Acid is a Risk Factor of Reduced Muscle Mass in Men with Type 2 Diabetes Mellitus

Meta-Analyses

56
Elgebaly, Ahmed; Abdelazeim, Nesrine; Abdelazeim, Bassant; El Ashal, Gehad; Mattar, Omar; Namous, Lubaba; Nasreldin, Noha: Tolerability and Efficacy of Ipragliflozin in The Management of Inadequately Controlled Type 2 Diabetes mellitus: A Systematic Review and Meta-analysis
Supplementary Material